Heidi Health Raises $340M for AI Clinical Agents

Australian healthcare AI startup Heidi Health has secured $340 million in new funding, comprising a $100 million Series C led by Blackbird and $240 million from General Catalyst. The capital will fuel global expansion of its AI Care Partner platform, which is already deployed across major health systems including Beth Israel Lahey Health in the U.S. and NHS England Midlands. Heidi's platform includes Scribe for ambient clinical documentation, Evidence for real-time medical research with 10 million queries answered since March, and Remote, a wearable hardware device. The company reports a 62% enterprise activation rate across public and private health systems, as physician AI adoption surpasses 81% in 2026.